AFT Pharmaceuticals Limited (ASX:AFP)
Australia flag Australia · Delayed Price · Currency is AUD
2.300
0.00 (0.00%)
Sep 1, 2025, 11:50 AM AEST

AFT Pharmaceuticals Revenue

In the fiscal year ending March 31, 2025, AFT Pharmaceuticals had annual revenue of 208.02M NZD with 6.45% growth. AFT Pharmaceuticals had revenue of 121.31M in the half year ending March 31, 2025, with 33.47% growth.

Revenue
208.02M NZD
Revenue Growth
+6.45%
P/S Ratio
1.30
Revenue / Employee
1.75M NZD
Employees
119
Market Cap
244.80M AUD

Revenue Chart

* This company reports financials in NZD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025208.02M12.61M6.45%
Mar 31, 2024195.41M38.77M24.75%
Mar 31, 2023156.64M26.33M20.20%
Mar 31, 2022130.31M17.21M15.22%
Mar 31, 2021113.11M7.51M7.11%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CSL Limited23.73B
Pro Medicus212.98M
Cochlear2.34B
Sonic Healthcare9.65B
Ramsay Health Care17.79B
Ansell3.06B
Telix Pharmaceuticals1.01B
Mesoblast26.23M
Revenue Rankings